EUVIMEDEUVIMED entdecken
Crossref

Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease

Rui Dong, Ting Tian, Zhenghan Luo, Dongchun Chang, Hong Xue, Sen Qu, Jia Wang, Chao Shen, Ru Zhang, Jie Wang

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2024.103797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Rui Dong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental and Community Nursing, School of Nursing, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Metabolic Syndrome, Fatty Liver, Blood Glucose. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: 333 Project of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) often manifest a combination of cardiometabolic risk factors of varying severity. The cardiometabolic phenotypes and their associations with advanced liver fibrosis and all-cause mortality among patients with MASLD warrant further investigation. METHODS AND RESULTS: A total of 4209 and 1901 eligible participants were obtained from the National Health and Nutrition Examination Survey and included in the original and replication datasets, respectively. In the original dataset, three distinct and stable cardiometabolic phenotypes were identified using unsupervised cluster analyses, including mild cardiometabolic risk factor (MCMRF) phenotype, overweight combined with high diastolic blood pressure dominated (OCHBP) phenotype, and severe glucose and lipid metabolic dysfunction dominated (SGLMD) phenotype. The above phenotypes were subsequently replicated in the replication dataset, demonstrating similar characteristics. After adjusting for potential covariates, the results of logistic and Cox regression models showed that OCHBP and SGLMD phenotypes were significantly associated with higher odds of advanced liver fibrosis (OCHBP: OR = 4.37, 95 % CI: 1.54-12.35, P = 0.020; SGLMD: OR = 9.66, 95 % CI: 4.76-19.61, P = 0.002) and an increased risk of all-cause mortality (OCHBP: HR = 1.39, 95 % CI: 1.17-1.65, P < 0.001; SGLMD: HR = 2.51, 95 % CI: 1.86-3.40, P < 0.001) compared to the MCMRF phenotype. Moreover, the observed associations remained statistically significant in most subgroups, and a series of sensitivity analyses further confirmed the robustness of these findings. CONCLUSION: Three heterogeneous cardiometabolic phenotypes were identified among participants with MASLD, showing significant associations with two critical outcomes. These novel phenotypes may be of great importance to precision medicine in MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisMetabolic SyndromeFatty LiverBlood GlucoseNon-alcoholic Fatty Liver DiseaseHypertensionHumansMalePhenotypeFemaleMiddle AgedCardiometabolic Risk FactorsNutrition SurveysRisk AssessmentUnited StatesAgedAdultBiomarkersPrognosisCause of DeathCross-Sectional Studies

Stichwörter der Autor:innen

Blood pressureCardiometabolicGlucoseHigh-density lipoprotein cholesterolLipidObesityTriglyceridesWaist circumference

Substanzen

BiomarkersBlood Glucose

Autor:innen und Institutionen

  • Department of Fundamental and Community Nursing, School of Nursing, Nanjing Medical University, Nanjing, China.
  • Institute of Nutrition and Food Safety, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Department of Infectious Disease Prevention and Control, Huadong Research Institute for Medicine and Biotechniques, Nanjing, China.
  • Department of Liver Disease, Third Affiliated Hospital of Nantong University, Nantong, China.
  • Department of Immunization Program, Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China.
  • School of Nursing and Midwifery, Jiangsu College of Nursing, Huaian, China. Electronic address: zr94131007@163.com.

Förderung

  • 333 Project of Jiangsu Province

Zitieren

APA

Dong, R., Tian, T., Luo, Z., Chang, D., Xue, H., Qu, S., Wang, J., Shen, C., Zhang, R., & Wang, J. (2025). Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2024.103797

Vancouver

Dong R, Tian T, Luo Z, Chang D, Xue H, Qu S, et al. Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2024.103797

BibTeX
@article{Dong2025,
  author = {Dong, Rui and Tian, Ting and Luo, Zhenghan and Chang, Dongchun and Xue, Hong and Qu, Sen and Wang, Jia and Shen, Chao and Zhang, Ru and Wang, Jie},
  title = {Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2024.103797}
}
Kostenlos starten →